Recently added articles from Heart Disease Weekly:
ACC/AHA revised guidelines for the perioperative use of beta blockers to minimize cardiac risk.
Nov 22, 2009 ... Cardiac complications around the time of noncardiac surgery are relatively common and can be serious. The American College of Cardiology (ACC) and the American Heart Association (AHA) release a Focused Update to the Practice Guidelines based on new clinical trial data that summarizes and ...
Combining calcium scoring and SPECT imaging gives more accurate read on patients' heart risk.
Nov 22, 2009 ... By relying solely on a patient's clinical risk profile or the results of one imaging test when assessing patients with chest pain, physicians may be missing important, early signs of atherosclerotic disease and opportunities to intervene, according to new findings published in the November ...
Say yes to a clinical trial; it may be good for your health.
Nov 22, 2009 ... Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the November European Journal of Heart Failure.(1) The finding, say the authors, may even call into question the commonplace ethical ...
US and Europe different in aldosterone antagonists use in heart failure.
Nov 22, 2009 ... A study published in JAMA (October 21) by Nancy M. Albert and colleagues, exploring aldosterone antagonist usage among US patients hospitalised with heart failure, found that only one-third of patients meeting current US Clinical Practice Guidelines criteria were actually being treated (1) ...
Human clinical study finds benefits linked to XanGo Juice.(Clinical report)
Nov 22, 2009 ... A new study published in Nutrition Journal indicates that XanGo[R] Juice, a market-leading, premium mangosteen beverage, has lowered levels of C-reactive protein (CRP) in overweight and obese people in a randomized, double-blind, placebo-controlled human trial. CRP is a marker used to ...